Table 2 Baseline laboratory values by CKD stage, mean (SD)
CKD Stage | Hgb, g/dL | TSAT, % | Ferritin, μg/L | |||
|---|---|---|---|---|---|---|
Ferumoxytol Treatment Group | Iron Sucrose Treatment Group | Ferumoxytol Treatment Group | Iron Sucrose Treatment Group | Ferumoxytol Treatment Group | Iron Sucrose Treatment Group | |
All stages | 9.1 (1.04) (n = 486) | 9.2 (1.11) (n = 280) | 8.7 (12.93) (n = 486) | 9.4 (12.40) (n = 280) | 68.8 (170.04) (n = 481) | 88.6 (184.48) (n = 279) |
Stage 1 (eGFR ≥90 mL/min) | 8.8 (0.95) (n = 280) | 8.8 (0.98) (n = 126) | 5.8 (11.25) (n = 280) | 4.3 (5.21) (n = 126) | 14.1 (39.76) (n = 276) | 15.4 (53.11) (n = 125) |
Stage 2 (eGFR 60 to <90 mL/min) | 9.1 (1.0) (n = 104) | 8.9 (0.89) (n = 59) | 6.6 (5.7) (n = 104) | 5.1 (3.47) (n = 59) | 55.4 (138.26) (n = 103) | 22.7 (80.21) (n = 59) |
Stage 3 (eGFR 30 to <60 mL/min) | 9.3 (0.86) (n = 41) | 9.5 (0.88) (n = 33) | 13.4 (18.31) (n = 41) | 16.1 (22.18) (n = 33) | 106.6 (168.37) (n = 41) | 106.5 (157.15) (n = 33) |
Stage 4 (eGFR 15 to <30 mL/min) | 9.8 (0.84) (n = 23) | 10.0 (0.76) (n = 20) | 21.7 (19.41) (n = 23) | 17.0 (6.49) (n = 20) | 152.3 (123.03) (n = 23) | 141.4 (158.16) (n = 20) |
Stage 5 (eGFR <15 mL/min) | 10.2 (1.09) (n = 38) | 10.2 (1.10) (n = 42) | 22.3 (12.91) (n = 38) | 21.7 (14.76) (n = 42) | 411.3 (348.97) (n = 38) | 359.7 (287.65) (n = 42) |